Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American College of Cardiology

• Publication date

  2003-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(03)00393-0PMID 12798570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Pharmacogenomics: Current Status, Future Prospects

  2003cited by this paper
• Does the −514T gene promoter variant of hepatic lipase predict increased high-density lipoprotein levels and reduced risk of angiographic coronary artery disease?

  2003cited by this paper
• The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.

  2003cited by this paper
• Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

  2003influential reference
• Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.

  2003influential reference
• Antioxidant Vitamins and Lipid Therapy

  2002influential reference
• SNP judgments and freedom of association.

  2002cited by this paper
• A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Antioxidant vitamins and lipid therapy: end of a long romance?

  2002cited by this paper
• Getting ready for gene-based medicine.

  2002cited by this paper
• Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.

  2002cited by this paper
• Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

  2002cited by this paper
• Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease

  2001influential reference
• Replication validity of genetic association studies

  2001cited by this paper
• Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis

  2001cited by this paper
• Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease: The Copenhagen City Heart Study

  2000cited by this paper
• Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene.

  2000influential reference
• Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment

  2000cited by this paper
• Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.

  2000cited by this paper
• New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation.

  2000cited by this paper
• Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene‐environment interaction

  2000cited by this paper
• The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II.

  1999cited by this paper
• Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations

  1999cited by this paper
• Lipoproteins in Health and Diseases

  1999influential reference
• The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

  1998cited by this paper
• Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

  1998cited by this paper
• Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.

  1998cited by this paper
• A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.

  1997cited by this paper
• Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels.

  1997cited by this paper
• Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients.

  1997cited by this paper
• Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study.

  1997cited by this paper
• Hepatic Lipase Gene Polymorphisms Influence Plasma HDL Levels

  1997cited by this paper
• Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

  1996cited by this paper
• Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

  1994cited by this paper

• Therapies Targeting HDLc Levels and HDL Function

  2017cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• Genes associated with Atherosclerosis in type 2 diabetes mellitus

  2014cites this paper
• Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response

  2011cites this paper
• A Combination of Proatherogenic Single-Nucleotide Polymorphisms Is Associated with Increased Risk of Coronary Artery Disease and Myocardial Infarction in Asian Indians

  2009cites this paper
• Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

  2009cites this paper
• Combined Hepatic Lipase -514C/T and Cholesteryl Ester Transfer Protein I405V Polymorphisms Are Associated with the Risk of Coronary Artery Disease

  2009cites this paper
• CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.

  2008cites this paper
• Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.

  2007cites this paper
• The C‐480T hepatic lipase polymorphism is associated with HDL‐C but not with risk of coronary heart disease

  2006influential citation
• The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.

  2005cites this paper
• Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000.

  2005cites this paper
• Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.

  2005cites this paper
• Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.

  2004cites this paper
• The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis.

  2004cites this paper
• ASSOCIATION OF HEPATIC LIPASE AND ENDOTHELIAL LIPASE POLYMORPHISMS WITH VARIATION IN NMR LIPOPROTEIN SUBCLASSES IN CAUCASIAN, AFRICAN-AMERICAN AND AFRICAN-CARIBBEAN OLDER MEN

  2004cites this paper